Issue 1

Cautious Optimism in the Wake of JP Morgan Conference

Why not sign up for our future email newsletters? Sign up here.

Included in this issue:

LEAD STORY

Getting Your Molecule Thru the Clinic in these Challenging Times – a View from your CDMO Partners

Sponsored by Expert Insights and Orientation Marketing, a panel of senior executives from the development and manufacturing partners charged with scaling and supplying medicines to patients were optimistic about 2024, but reflected on some of the challenges the industry will face too.

Read more here.

FEATURED STORIES

Sanner Group strengthens medical device design and development capabilities with the acquisition of Springboard Pro

Read more here.

Nanoform Commenced Relative Bioavailability Study of Nanotechnology- Enhanced Enzalutamide

Read more here.

Bora Pharmaceuticals to Acquire US Pharma Manufacturer Upsher-Smith for $210 Million in Transaction to Fuel Global Expansion

Read more here.